mRNA |
Axitinib |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
5e-07 |
mRNA |
FQI-2 |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
6e-07 |
mRNA |
tipifarnib |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
6e-07 |
mRNA |
FK866 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
7e-07 |
mRNA |
BI-2536 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
8e-07 |
mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
9e-07 |
mRNA |
SB-225002 |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.15 |
1e-06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
mRNA |
parbendazole |
CTRPv2 |
pan-cancer |
AAC |
0.16 |
1e-06 |